Publication:
Effects of genetic deletion versus pharmacological blockade of the LPA1 receptor on depression-like behaviour and related brain functional activity.

No Thumbnail Available

Date

2018-07-13

Authors

Moreno-Fernandez, Roman Dario
Nieto-Quero, Andrea
Gomez-Salas, Francisco Javier
Chun, Jerold
Estivill-Torrus, Guillermo
Rodriguez-de-Fonseca, Fernando
Santin, Luis Javier
Perez-Martin, Margarita
Pedraza, Carmen

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

The Company of Biologists
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Animal models of psychopathology are particularly useful for studying the neurobiology of depression and characterising the subtypes. Recently, our group was the first to identify a possible relationship between the LPA1 receptor and a mixed anxiety-depression phenotype. Specifically, maLPA1-null mice exhibited a phenotype characterised by depressive and anxious features. However, the constitutive lack of the gene encoding the LPA1 receptor (Lpar1) can induce compensatory mechanisms that might have resulted in the observed deficits. Therefore, in the present study, we have compared the impact of permanent loss and acute pharmacological inhibition of the LPA1 receptor on despair-like behaviours and on the functional brain map associated with these behaviours, as well as on the degree of functional connectivity among structures. Although the antagonist (intracerebroventricularly administered Ki16425) mimicked some, but not all, effects of genetic deletion of the LPA1 receptor on the results of behavioural tests and engaged different brain circuits, both treatments induced depression-like behaviours with an agitation component that was linked to functional changes in key brain regions involved in the stress response and emotional regulation. In addition, both Ki16425 treatment and LPA1 receptor deletion modified the functional brain maps in a way similar to the changes observed in depressed patients. In summary, the pharmacological and genetic approaches could ultimately assist in dissecting the function of the LPA1 receptor in emotional regulation and brain responses, and a combination of those approaches might provide researchers with an opportunity to develop useful drugs that target the LPA1 receptor as treatments for depression, mainly the anxious subtype.This article has an associated First Person interview with the first author of the paper.

Description

MeSH Terms

Animals
Behavior, Animal
Brain
Depression
Gene Deletion
Mice, Inbred C57BL
Principal Component Analysis
Receptors, Lysophosphatidic Acid

DeCS Terms

Receptores del Ácido Lisofosfatídico
Encéfalo
Depresión
Regulación Emocional
Neurobiología
Psicopatología

CIE Terms

Keywords

Animal models, Antagonist, Functional brain mapping, Genetic deletion, LPA1 receptor, Mixed anxiety-depression phenotype

Citation

Moreno-Fernández RD, Nieto-Quero A, Gómez-Salas FJ, Chun J, Estivill-Torrús G, Rodríguez de Fonseca F, et al. Effects of genetic deletion versus pharmacological blockade of the LPA1 receptor on depression-like behaviour and related brain functional activity. Dis Model Mech. 2018 Sep 10;11(9):dmm035519